Related by context. All words. (Click for frequent words.) 72 vascular disrupting agents 72 OvaRex R 71 MEK inhibitors 71 Panzem R NCD 70 tubulin inhibitor 70 Xanafide 70 predictive biomarkers 70 YONDELIS 70 Personalized Immunotherapy 70 Onconase 70 oral prodrug 70 dasatinib Sprycel 70 CYT# potent vascular disrupting 70 orally administered inhibitor 70 YONDELIS R 70 PXD# 70 isoform selective 70 Pertuzumab 69 CBLC# 69 Squalamine 69 Immunotherapeutic 69 HGS# 69 thalidomide Thalomid 69 immune modulating 69 cMET 69 polyglutamate 69 JAK inhibitors 69 immunomodulation 69 HuLuc# 69 preclinically 69 alvespimycin 69 tiapamil 69 selective modulator 69 IMA# 69 vidofludimus 69 Symadex 69 receptor tyrosine kinase inhibitor 69 HQK 69 cilengitide 68 Factor VIIa 68 THR beta agonist 68 biologic therapeutics 68 Archexin 68 Omacetaxine 68 Tyrima 68 IAP inhibitors 68 kidney urologic 68 anti angiogenic agents 68 Aplidin 68 p# inhibitor 68 AEG# 68 histone deacetylase inhibitor 68 PI3K/mTOR 68 SPRYCEL ® 68 Panzem 68 Exelixis XL# 68 targeting CD# 68 molecularly targeted 68 rxRNA 68 proteasome inhibitor 68 ospemifene 68 Eribulin 68 HCV protease inhibitors 68 PEG SN# 68 ganetespib 68 renin inhibitors 68 metaglidasen 68 immune modulatory 68 GMX# 68 HSP# inhibitor 67 oral picoplatin 67 Evoltra ® 67 XmAb# 67 Granulocyte Colony Stimulating Factor 67 PNP inhibitor 67 gefitinib Iressa 67 fosbretabulin 67 Celator 67 Curaxin 67 PDE4 inhibitor 67 beta 1a 67 multitargeted 67 histone deacetylase HDAC 67 investigational therapies 67 radezolid 67 Triapine 67 Anavex #-# 67 pan HDAC inhibitor 67 Adnectin 67 Dalbavancin 67 kinase inhibition 67 Sudhir Agrawal D.Phil 67 anticoagulant reversing agent 67 PI3K/Akt pathway inhibitor 67 delta isoform 67 Thiovir 67 depsipeptide 67 Angiocept 67 sorafenib Nexavar 67 HIV integrase inhibitors 67 CCR9 antagonist 67 vascular disrupting agent 67 forodesine 67 generation purine nucleoside 67 siRNA therapeutics 67 Fludara ® 67 acadesine 67 FOLOTYN ® 67 Temsirolimus 67 therapeutic monoclonal antibody 67 Annamycin 67 proteasome inhibitors 67 diagnostic biomarkers 67 delafloxacin 66 demethylating agent 66 cediranib 66 ENMD # 66 Kahalalide F 66 Pimavanserin 66 mGlu2 3 66 Aviptadil 66 antisense inhibitors 66 AKT inhibitor 66 DCVax R 66 bevacizumab Avastin ® 66 erlotinib Tarceva ® 66 Campath ® 66 JAK inhibitor 66 Monoclonal antibody 66 HDACi 66 Panzem R 66 FGFR 66 targeting PCSK9 66 OMAPRO 66 Clolar ® 66 IMiDs R 66 anti fibrotic 66 sorafenib tablets 66 immunotherapeutic vaccine 66 Abiraterone acetate 66 celgosivir 66 lymphoid malignancies 66 CINQUIL 66 Vidofludimus 66 TACI Ig 66 refractory chronic lymphocytic 66 pharmacodynamic markers 66 enzastaurin 66 uric acid lowering 66 mTOR inhibitors 66 novel anticancer 66 histamine dihydrochloride 66 CDK inhibitor 66 Ceflatonin R 66 obatoclax 66 Tasimelteon 66 LHRH antagonists 66 ASONEP 66 atacicept 66 PKC# 66 RIGScan CR 66 BCR ABL inhibitors 66 pharmacogenetic 66 JAK1 66 selective inhibition 66 Vidaza azacitidine 66 endothelin antagonists 66 Preclinical studies suggest 66 SUTENT ® 66 small molecule activators 66 Phase IIb clinical trials 66 DNA methyltransferase inhibitors 66 Mipomersen 66 SNT MC# 66 Deforolimus 66 novel VDA molecule 66 anti CD3 66 Virulizin ® 66 MAGE A3 ASCI 66 Maribavir 66 antiangiogenic 66 thiazolides 66 Cloretazine R 66 cetuximab Erbitux R 66 potent suppressor 66 JAK2 inhibitor 66 NS5A 66 liposomal formulation 66 Chemophase 66 EP #R 66 Gastrointestinal Stromal Tumors 66 IMiDs 66 ixabepilone 66 antiangiogenesis 66 Gleevec resistant 65 tezampanel NGX# 65 ACCLAIM II 65 epothilone 65 targeted radiotherapeutic 65 LibiGel ® 65 M# rationally 65 Ceflatonin 65 Aurora Kinase 65 Fabry Disease 65 DGAT 65 investigational humanized monoclonal antibody 65 Nanobody ® 65 Micromet BiTE 65 Cloretazine 65 Quinamed 65 regorafenib 65 TPI ASM8 65 Interferon beta 65 nicotinic alpha 7 65 Plicera 65 Pyridorin 65 TELINTRA 65 ALK inhibitors 65 Safinamide 65 vinca alkaloid 65 Sapacitabine 65 pertuzumab 65 pharmacodynamic parameters 65 predictive toxicology 65 neratinib 65 antitumoral 65 XYOTAX TM 65 Dasatinib 65 novel peptide 65 rNAPc2 65 Azacitidine 65 ALN TTR 65 selective kinase inhibitor 65 ONCONASE R 65 myelofibrosis polycythemia vera 65 imatinib resistance 65 Tesmilifene 65 trastuzumab Herceptin R 65 Blinatumomab 65 StemEx 65 vivo preclinical 65 CR# vcMMAE 65 JAK#/JAK# 65 HuMax EGFr 65 p# biomarker 65 breast cancer subtypes 65 PDX pralatrexate 65 HGS ETR2 65 viral kinetics 65 TransVax ™ 65 DXL# 65 Chimigen TM 65 heparanase 65 receptor inhibitor 65 protein tyrosine phosphatase 1B 65 DNA methyltransferases 65 Cloretazine ® 65 antiangiogenic agents 65 EGS# 65 Recombinant Human 65 OvaRex ® MAb 65 protein kinase inhibitors 65 sargramostim 65 cancer immunotherapies 65 Leukine ® 65 CD# CEA 65 RhuDex TM 65 deforolimus 65 nucleoside analog 65 sunitinib malate 65 clevidipine 65 pharmacokinetic interactions 65 GW# [003] 65 OXi# 65 insulin sensitizing 65 SERMs 65 Vidaza ® 65 EndoTAG TM 65 ALN PCS 65 mediated inhibition 65 FOLFOX6 chemotherapy regimen 65 IAP inhibitor 65 Ecallantide 65 peptidomimetic 65 velafermin 65 CD# monoclonal antibody 65 molecular biomarkers 65 diagnostic biomarker 65 fusion enhancers 65 Solazed TM 65 AAG geldanamycin analog 65 Poly ICLC 65 immuno modulatory 65 Fc fusion protein 65 Aplidin R 65 molecular imaging radiopharmaceutical 65 optimal dosing regimens 65 anti CD# antibodies 65 phase IIb clinical 65 eTag assays 65 cutaneous T 65 VEGF inhibitors 65 epothilones 65 imatinib Gleevec 65 Romidepsin 65 myeloproliferative disorders 65 Tumour Vascular Disrupting Agent 65 decitabine 65 selective orally bioavailable 65 R sorafenib tablets 65 RNA antagonists 65 telomerase therapeutic 65 Elvitegravir 65 PrevOnco 65 MGd 65 antitumour 65 ® bortezomib 65 galiximab 65 polymerase inhibitors 65 IL# PE#QQR 65 Anticalin ® 65 Hsp# Inhibitor 65 Vidaza R 65 CLORETAZINE TM VNP#M 65 IMC #B 65 Oracea TM 65 Spiegelmer ® 65 Antiangiogenic 65 novel therapeutic antibodies 65 antimitotic 65 brostallicin 65 synthetic retinoid 65 human microdosing 65 nucleotide analogs 65 novel oral anticoagulant 65 reslizumab 65 antibody MAb 65 CRMD# 65 anti amnesic 65 A3 adenosine receptor 65 ganaxolone 65 flavopiridol 65 bortezomib Velcade 65 pomalidomide 65 Cytochrome P# 65 TLK# 65 immunomodulating 65 Genz # 65 IRX 2 65 OMNARIS HFA 65 RNAi therapeutic targeting 65 IMiDs ® 65 demethylating agents 65 Epothilones 65 BLyS specific 65 imatinib Gleevec ® 65 volociximab 64 2 methoxyestradiol 64 zanolimumab 64 CA4P 64 trastuzumab DM1 T DM1 64 UPLYSO 64 Azedra 64 Phase Ib II 64 Ixabepilone 64 mTOR kinase 64 vivo pharmacology 64 novel immunomodulatory 64 #ME# 64 vitro assay 64 Bucindolol 64 Removab 64 Glufosfamide 64 intranasal delivery 64 Cytotoxic 64 NEUGENE 64 TLR antagonists 64 PDE# inhibitors 64 EGFR pathway 64 PRT# 64 Generx TM 64 OMP #M# 64 antifolates 64 vemurafenib 64 DCCR 64 nucleoside tide 64 bevacizumab Avastin R 64 XmAb 64 eprotirome 64 thetreatment 64 TKB# 64 glucokinase activator 64 oral antiviral 64 inhibit metastasis 64 effector function 64 TLR9 agonist 64 novel emulsion formulation 64 Civacir 64 Icatibant 64 Intravenous CP 64 protein tyrosine kinase 64 sapacitabine 64 Carfilzomib 64 HCD# [002] 64 Daniel Junius 64 Bortezomib 64 GPCR targets 64 Pafuramidine 64 Cardiotoxicity 64 Myocet 64 pediatric acute lymphoblastic 64 triphendiol 64 torezolid phosphate 64 ELACYT 64 REG1 64 incyclinide 64 non nucleoside HCV 64 EndoTAGTM 1 64 nalbuphine ER 64 Cloretazine VNP#M 64 Phase #/#a trial 64 selective androgen receptor modulators 64 registrational trial 64 Modrenal 64 PDE inhibitors 64 nilotinib Tasigna 64 VeraTag 64 BRAF inhibitor 64 vorinostat 64 Teplizumab 64 immune modulation 64 CD# antibody [001] 64 lumiliximab 64 Protexia ® 64 endothelin receptor antagonists 64 small molecule tyrosine 64 ISTODAX 64 eniluracil 64 Afatinib 64 virus HCV protease inhibitor 64 Anidulafungin 64 cytokine refractory 64 IMC A# 64 anti angiogenic drugs 64 Lenalidomide 64 NOX E# 64 entinostat 64 Muraglitazar 64 selective adenosine 64 Triapine R 64 Clofarabine 64 TOCOSOL Camptothecin 64 theranostic 64 PRTX 64 PSN# [002] 64 faropenem 64 5 HT2A serotonin 64 ZK EPO 64 preclinical efficacy 64 myeloproliferative diseases 64 potent anticancer 64 BAY #-# 64 Marqibo TM 64 anti mitotic 64 Harry Palmin President 64 Locked Nucleic Acid LNA 64 lapatinib Tykerb 64 Tezampanel 64 peripherally acting 64 Alfacell proprietary ribonuclease 64 MDV# 64 MAXY G# 64 immunoregulatory 64 CTAP# Capsules 64 CCX# 64 CCR5 antagonist 64 oral talactoferrin 64 MEK inhibitor RDEA# 64 cannabinor 64 resolvins 64 SGLT2 inhibitors 64 Nexavar ® 64 Angiotensin converting enzyme 64 Novolimus 64 pharmacogenetic testing 64 NPC 1C 64 Panzem NCD 64 INCB# [001] 64 nucleotide analog 64 peptide conjugated 64 modulators SERMs 64 oral proteasome inhibitor 64 ADP receptor antagonist 64 NTDDS 64 PEGylated interferon 64 non nucleoside inhibitor 64 Interferon Beta 64 Nexavar sorafenib 64 Sphingomab TM 64 Novosom 64 Allovectin 7 R 64 Epratuzumab 64 CEQ# 64 TransVax tm 64 mGluR2 NAM 64 Potelligent Technology 64 Trofex 64 PI3K Akt 64 synthetic siRNA 64 GSK3B 64 Orally administered 64 Capsulution 64 BZL# 64 TAFA# 64 Technosphere ® 64 biomarker identification 64 Bicifadine 64 prognostic markers 64 DOS# 64 TRO# 64 Allovectin 7 64 VKORC1 64 Surfaxin LS 64 CMV vaccine 64 ZOLINZA 64 Elotuzumab 64 LEUKINE 64 pharmacodynamic PD 64 MOZOBIL 64 HDL Mimetic Peptide 64 PrevOnco ™ 64 ThermoDox ® clinical 64 MEK inhibitor 64 histone deacetylase HDAC inhibitors 64 Fulvestrant 64 signal transduction inhibitors 64 Voreloxin 64 TO AVOID PREGNANCY WHILE 64 XP #L 64 DPX Survivac 64 SYN# 64 chimeric monoclonal antibody 64 BENLYSTA ® 64 beta secretase inhibitors 64 elotuzumab 64 PDGF receptor 64 Insegia 64 Janus kinase 64 systemic fungal infections 64 midstage clinical 64 antimetabolites 64 HepDirect R 64 ATL# [001] 64 potent antiproliferative 64 tanespimycin 64 INT# [002] 64 hypereosinophilic syndrome 64 MGN# 64 tumor vascular disrupting 64 TroVax ® 63 Presents Preclinical Data 63 Trofex TM 63 mTOR mammalian target 63 neuro protective 63 IMiDs ® compound 63 investigational HCV polymerase 63 immunomodulatory 63 immune modulator 63 CRLX# 63 ON #.Na 63 HCV polymerase inhibitors 63 refractory AML 63 ALN TTR# 63 ProLindac TM 63 non nucleoside 63 defensin mimetic antibiotic 63 mertansine 63 Azedra TM 63 Fc gamma receptor 63 DPP4 inhibitor 63 Aeolus Pharmaceuticals Announces 63 cetuximab Erbitux ® 63 Zemiva TM 63 Hedgehog Pathway Inhibitor 63 investigational monoclonal antibody 63 direct thrombin inhibitors 63 RhuDex ® 63 Omnitarg 63 Gleevec imatinib mesylate 63 therapeutic peptide 63 CYP#A# CYP#D# 63 inhibit viral replication 63 Systemic Delivery 63 mda 7 63 tumor subtypes 63 forodesine hydrochloride 63 Phase #b/#a clinical 63 cardio renal 63 KL4 surfactant 63 relapsed MM 63 rhFVIIa 63 personalized immunotherapy 63 pathophysiological effects 63 NNR Therapeutics 63 MCSP respectively 63 SinuNase ™ 63 Lixivaptan 63 rALLy clinical trial 63 Aflibercept 63 compound AEZS 63 Hedgehog inhibitor 63 targeted antifolate 63 CobaCyte 63 Talabostat 63 anticancer therapies 63 benzimidazole 63 favorable pharmacokinetic profile 63 Nanobody 63 tramiprosate Alzhemed TM 63 ARIKACE ™ 63 antiproliferative effects 63 receptor agonists 63 Camvia 63 poly ADP ribose polymerase 63 pharmacodynamic biomarkers 63 Vorinostat 63 NS5B polymerase 63 immunotherapeutic approaches 63 Tß4 63 otelixizumab 63 Apoptone 63 CCR5 inhibitor 63 IL-#/# 63 RhuDex R 63 Isis antisense 63 intracellular signaling pathways 63 Campath alemtuzumab 63 RGB # 63 PANVAC VF 63 Ophena 63 Fodosine 63 Tarvacin Anti Viral 63 immatics 63 candidates Azedra TM 63 Anti angiogenic 63 Lisofylline 63 BRAF inhibitors 63 metabonomics 63 cytoprotective 63 Prodarsan R 63 Pivotal Phase III 63 thymidylate synthase TS 63 NS5b 63 Dr. McHutchison 63 evaluating tivozanib 63 Bazedoxifene 63 ADME Tox 63 tranilast 63 Catena ® 63 ART# 63 Bendamustine 63 selective estrogen receptor modulator 63 Lpathomab 63 Ramoplanin 63 immunosuppressant therapies 63 antithrombotic 63 Transfection Reagent 63 RNAi therapeutic targeting PCSK9 63 Silodosin 63 demonstrated antitumor activity 63 Initiates Enrollment 63 renin inhibition 63 Poly ICR 63 antiapoptotic 63 PPARgamma 63 Bioral ® 63 pain palliation 63 vitro ADME 63 DNA demethylating agent 63 MTP inhibitor 63 treating neuropathic pain 63 Bayer HealthCare Onyx Pharmaceuticals 63 trastuzumab DM1 63 CRACM 63 Alzhemed TM 63 K ras mutations 63 Inhalation Solution 63 Warfarin Coumadin 63 ceftazidime 63 VDAs 63 Aurora kinase 63 HER1 63 Trandolapril 63 ADME properties 63 Arno Therapeutics 63 novel immunotherapeutic 63 Altastaph 63 EndoTAG TM -1 63 CYC# 63 GFT# 63 oral taxane 63 Curaxin CBLC# 63 Aganocide 63 Maxy G# 63 Lenocta 63 Theranostics 63 chemopreventive agents 63 alemtuzumab MS 63 Guanilib 63 immunomodulatory properties 63 ATL/TV# 63 AMD# [003] 63 Hoyoung Huh MD Ph.D. 63 humanised antibody 63 immune stimulatory 63 Pegylated 63 orBec 63 GALNS 63 enzyme inhibitor 63 Akt inhibitor 63 oxidative stress inducer 63 JAK3 63 lorvotuzumab mertansine 63 Epidermal Growth Factor Receptor 63 PSN# [001] 63 Anti VEGF 63 tyrosine kinase inhibitors 63 bardoxolone 63 Pazopanib 63 immunomodulators 63 SGLT 2 63 leukotriene receptor antagonist 63 NEUGENE R 63 hypoxia activated prodrug 63 antitumor efficacy 63 IIa clinical 63 Neulasta ® 63 Homspera TM 63 VitiGam 63 Meets Primary Endpoint 63 Alferon N 63 vivo validation 63 Fenretinide 63 HuMax CD4 63 calcineurin inhibitors 63 biologic pathways 63 somatostatin analogues 63 BIM #A# 63 Kinases 63 monoclonal antibody MAb 63 Solorel TM 63 Tarvacin TM 63 R#/MEM # 63 GAP #B# 63 bioinformatic approaches 63 Telatinib 63 PIK3CA 63 R Saizen R 63 small molecule defensin 63 JAK2 Inhibitor 63 Vaxfectin 63 mechanistic insights 63 Targretin 63 TMEM#B 63 Elagolix 63 Solulin 63 liposomal delivery 63 Vilazodone 63 PSMA ADC 63 samalizumab 63 orally bioavailable 63 Aurora kinase inhibitor 63 anticancer agent 63 essential thrombocythemia ET 63 trastuzumab Herceptin 63 Hsp# inhibition 63 MKC# MKC# PP 63 EGFR HER 63 intranasal formulation 63 macrolide antibiotics 63 adecatumumab 63 antiangiogenic therapy 63 Janus Kinase 63 pharmacodynamic properties 63 BLP# Liposome Vaccine 63 LAB CGRP 63 anticancer therapeutics 63 therapeutic monoclonal antibodies 63 MEND CABG II 63 romidepsin 63 Martin Nicklasson CEO 63 Smac mimetics 63 PGL# 63 Perforomist ™ Inhalation Solution 63 Phase 2b Clinical Trial 63 phase IIa clinical 63 Initiates Clinical 63 fibrotic disease 63 LEAPS TM 63 K RAS 63 mitotic kinesins 63 DACH platinum 63 c MET 63 chemopreventive agent 63 Valortim ® 63 PI3K inhibitors 63 IDO inhibitor 63 Angiotensin Converting Enzyme 63 antithrombotics 63 Onalta 63 humanized anti 63 TLR agonists 63 Velcade bortezomib 63 Spiegelmer 63 induced macular edema 63 Prodarsan ® 63 neuronal nicotinic receptors NNRs 63 antisense drug 63 Tarvacin 63 Ostabolin C TM 63 novel peptides 63 radiation sensitizer 63 antibody cytokine 63 Pemetrexed 63 ARRY # 63 masitinib 63 Exelixis compounds 63 ALTROPANE R 63 small molecule agonists 63 Virulizin R 63 XL# anticancer compounds 63 Uvidem 63 lenalidomide Revlimid 63 Phase #b/#a trial 63 edifoligide E2F Decoy 63 DermaVir Patch 63 IGF IR 63 Fx #A 63 Cethromycin 63 Tyrosine Kinase Inhibitor 63 Varespladib 63 pro angiogenic 63 Pegloticase 63 HCV protease 63 Ampligen ® 63 CG# [003] 63 anti thrombotic 63 Dyax phage display 63 5 fluorouracil leucovorin 63 BioNumerik 63 peptibody 63 humanized monoclonal 63 mTOR inhibitor 63 CA9 SCAN 63 XL# XL# 63 phosphate S1P 63 3 kinase PI3K 63 paclitaxel Taxol 63 Cetrorelix 63 SinuNase TM 63 geldanamycin 63 Amigal 63 Multimeric 63 estrogen receptor beta 63 oral JAK1 62 Bioral Amphotericin B 62 adrenergic regulation 62 HCV polymerase 62 T#I [002] 62 Liposomal 62 plasma kallikrein inhibitor 62 antisense oligonucleotides 62 JAK2 inhibitors 62 MDS AML 62 oxaliplatin Eloxatin 62 indibulin 62 PPARγ 62 Androxal ® 62 inhibit KSP 62 aurora kinase 62 gemcitabine Gemzar ® 62 selective inhibitors 62 unique alkylating agent 62 Therapeutic antibodies 62 aripiprazole Abilify 62 cytostatic 62 potently inhibit 62 treat chronic sinusitis 62 BAL# [002] 62 KRAS mutant 62 EGFR mutation status 62 VIBEX MTX 62 DU #b 62 neuronal nicotinic receptor NNR 62 GLP toxicology studies 62 Sphingomab 62 endothelin receptor 62 endothelin antagonist 62 Tovaxin TM 62 factor VIIa 62 torsemide ER 62 Pancreate 62 Stapled Peptide 62 Xeloda ® 62 Factor Receptor 62 Zybrestat 62 CCR5 mAb 62 tiuxetan 62 nitric oxide donating prostaglandin 62 SILENOR 62 HyACT 62 Rigel R# 62 TMC# [002] 62 inhibiting tumor 62 Firazyr ® 62 octreotide implant 62 polycythemia vera PV 62 clinically validated targets 62 Protein Kinase C 62 vivo potency 62 subcutaneous immunoglobulin 62 Biomerk Tumorgrafts 62 Flt3 62 recombinant biopharmaceutical 62 acetonide FA 62 cyclin dependent kinase inhibitor 62 Targretin capsules 62 voreloxin 62 anti angiogenic therapies 62 NPM1 62 L BLP# 62 novel histone deacetylase 62 PI3K inhibitor 62 paclitaxel Taxol ® 62 TNF α 62 bendamustine 62 DXL TM 62 TRV# [001] 62 BrachySil TM 62 hematopoietic malignancies 62 Cutaneous T 62 Gleevec Glivec 62 AtherOx 62 Cx# [002] 62 Vitaxin 62 OMP #R# 62 Pharmacokinetics PK 62 Vicriviroc 62 eIF 4E 62 pharmacological chaperone 62 Kinase inhibitors 62 TransVax TM 62 R roscovitine 62 AQ4N 62 ChronVac C R 62 investigational hepatitis C 62 tumorigenicity 62 Capesaris 62 Posiphen TM 62 Ampakine 62 selective A2A adenosine receptor 62 MAb 62 Curaxins 62 MYCAMINE 62 Ridaforolimus 62 Vandetanib 62 tigecycline 62 accumulate preferentially 62 Pralatrexate 62 oral Factor Xa 62 tubulin binding 62 Darinaparsin 62 VEGF receptor 62 Revlimid lenalidomide 62 Cathepsin S 62 transfection reagents 62 Phase #b/#a 62 druggable targets 62 Bezielle 62 GED aPC 62 sitaxsentan 62 Tarceva TM 62 receptor modulators 62 interleukin IL -# 62 FGFR3 62 therapeutic mAbs 62 DDP# 62 Immunomodulatory 62 lucinactant 62 multicenter Phase II 62 ONCASPAR 62 haematological cancers 62 Valproic acid 62 alpha#beta# integrin 62 Dr. Aiping Young 62 mapatumumab 62 Fc receptor 62 BGC# 62 Zavesca r